Immunocytochemistry (ICC) uses antibodies to detect and localise proteins in cultured cells while preserving cellular context. The protocol below is a general starting workflow for adherent cells grown on coverslips or chamber slides. Fixation, permeabilisation, antibody dilution and incubation conditions should be optimised for the target, cell type and antibody.
Important: where an antibody datasheet provides application-specific ICC/IF conditions, use those conditions in preference to this general protocol.
Protocol at a glance
| Best suited to | Localising proteins in adherent cultured cells while preserving cellular morphology. |
|---|---|
| Typical readout | Fluorescence intensity and subcellular localisation by widefield or confocal microscopy. |
| Critical variables | Fixation chemistry, permeabilisation strength, antibody specificity, fluorophore choice and imaging settings. |
| Minimum controls | Positive biological control, negative/KO control where possible, no-primary control and single-colour controls for multiplex work. |
| Common failure mode | Good-looking fluorescence caused by non-specific staining or overexposure rather than true target signal. |
Equipment required
- Cell culture plates, chamber slides or sterile glass coverslips
- Humidified staining chamber
- Pipettes and low-retention tips
- Forceps for coverslip handling
- Fluorescence microscope with filter sets matched to the fluorophores
- Light-protected slide box or chamber
Reagents
- Phosphate-buffered saline (PBS)
- Fixative, commonly 4% paraformaldehyde/formaldehyde in PBS
- Permeabilisation reagent, commonly Triton X-100, saponin or another target-compatible detergent
- Blocking reagent such as normal serum from the secondary-antibody host species or bovine serum albumin (BSA)
- Primary antibody validated or suitable for ICC/IF
- Fluorophore-conjugated secondary antibody where indirect detection is used
- Nuclear counterstain such as DAPI, if required
- Antifade mounting medium
Before starting
- Grow cells so individual cells and subcellular structures can still be resolved at imaging.
- Choose fixation around the target. Formaldehyde preserves morphology well, but some epitopes may perform better with alcohol-based fixation.
- For intracellular targets after aldehyde fixation, plan a permeabilisation step. Membrane-associated targets can be sensitive to harsh detergents.
- Protect fluorophores from unnecessary light exposure from the secondary-antibody step onwards.
ICC procedure
- Prepare cells. Grow adherent cells on sterile coverslips or chamber slides. If the cell type adheres poorly, use an appropriate validated coating such as poly-L-lysine, poly-D-lysine or another extracellular-matrix coating.
- Wash. Remove culture medium and gently wash the cells with PBS without allowing the monolayer to dry.
- Fix. A common starting condition is 4% paraformaldehyde/formaldehyde in PBS for approximately 10–20 minutes at room temperature. Published immunofluorescence protocols for cultured cells commonly use aldehyde fixation in this general range, but fixation should be treated as an assay variable rather than a universal constant. Optimise if morphology or epitope accessibility is poor.
- Wash three times with PBS. Gentle 5-minute washes are suitable for many adherent-cell workflows.
- Permeabilise if required. For intracellular targets after aldehyde fixation, use a target-compatible detergent. A practical starting range is approximately 0.1–0.3% Triton X-100 for about 5 minutes at room temperature; milder detergents such as saponin may be preferable for some membrane-associated antigens.
- Wash three times with PBS.
- Block. Cover cells with blocking buffer and incubate for about 1 hour at room temperature. Common blockers include 2–10% normal serum or BSA. Avoid using serum from the same species as the primary antibody where this could increase background.
- Incubate with primary antibody. Dilute the antibody in an appropriate antibody diluent or diluted blocking buffer. Use the validated datasheet dilution where available. Incubate for 1–2 hours at room temperature or overnight at 4°C in a humidified chamber.
- Wash three times. Use PBS or the validated wash buffer, typically for about 5 minutes per wash.
- Incubate with fluorescent secondary antibody. Apply a species-appropriate fluorophore-conjugated secondary antibody at its validated dilution for approximately 1 hour at room temperature protected from light.
- Wash three times protected from light.
- Counterstain if required. Add DAPI or another compatible nuclear stain according to the reagent instructions.
- Mount. Apply antifade mounting medium and coverslip carefully to avoid bubbles.
- Image. Use identical acquisition settings for samples that will be compared quantitatively or semi-quantitatively. Avoid saturated pixels.
Recommended controls
- No-primary control: omit the primary antibody but include the fluorescent secondary to assess secondary-antibody background.
- Positive control: use a cell line or treatment known to express the target.
- Negative biological control: use a target-negative, knockout or knockdown sample where available.
- Secondary-only / multiplex controls: useful when several secondary antibodies or fluorophores are used to check channel-specific cross-reactivity.
- Isotype control: may be useful for selected experiments, but should not replace biological positive/negative controls.
Optimisation notes
- Fixation: over-fixation can mask epitopes; under-fixation can compromise morphology.
- Permeabilisation: Triton X-100 is effective for intracellular access but can solubilise membranes and membrane-associated proteins.
- Blocking: insufficient blocking or a poorly matched serum can increase non-specific fluorescence.
- Antibody concentration: titrate both primary and secondary antibodies rather than assuming the highest concentration gives the best signal.
- Imaging: compare experimental groups using matched exposure, laser power, gain and post-processing.
Recommendations and warnings
- Do not optimise fixation and antibody dilution at the same time. Change one variable at a time so you can identify the reason signal improves or fails.
- Do not let coverslips dry after fixation. Drying can increase background and damage morphology.
- Membrane proteins need gentler permeabilisation. Strong Triton X-100 treatment can extract membrane-associated proteins and create an apparently negative result.
- Quantitative imaging requires an unsaturated detector. If any important pixels are saturated, fluorescence intensity cannot be interpreted quantitatively.
- Antibody specificity is more important than brightness. A strong signal without knockout/knockdown, expected localisation or an orthogonal validation method can still be non-specific.
- For multiplex ICC, check spectral spillover experimentally. Run single-colour controls and avoid choosing fluorophores with substantial emission overlap where possible.
How to optimise ICC systematically
A useful first optimisation matrix is a small fixation × antibody-titration experiment. Keep imaging settings constant, compare one or two fixation/permeabilisation conditions, and test a short primary-antibody dilution series. Select the condition that maximises biologically plausible signal-to-background rather than absolute fluorescence.
Limitations
- Fixation can alter epitope accessibility and cell morphology.
- Fluorescence intensity is not automatically proportional to protein abundance unless the staining and imaging workflow is validated for quantitative use.
- Autofluorescence, spectral overlap and photobleaching can complicate multiplex imaging.
- Antibody specificity must be established independently; a visually convincing pattern does not by itself demonstrate specificity.
Troubleshooting
| Problem | Possible cause | What to try |
|---|---|---|
| Weak or absent signal | Low target abundance, over-fixation, insufficient permeabilisation or suboptimal antibody dilution | Confirm a positive control, optimise fixation/permeabilisation, and titrate the primary antibody. |
| High background | Insufficient blocking, excessive antibody, non-specific secondary binding or autofluorescence | Increase blocking, reduce antibody concentration, use highly cross-adsorbed secondaries and review fluorophore choice. |
| Poor morphology | Harsh permeabilisation or inappropriate fixation | Reduce detergent concentration/time or compare an alternative fixative. |
| Uneven staining | Cells dried during staining or reagent did not cover the specimen evenly | Keep cells hydrated and ensure complete reagent coverage in a humidified chamber. |
| Signal in negative sample | Non-specific antibody binding or channel bleed-through | Review biological controls, secondary-only controls, filter sets and acquisition settings. |
Frequently asked questions
What is the difference between ICC and immunofluorescence?
ICC describes antibody staining of cultured cells; immunofluorescence describes fluorescent antibody detection more broadly and can also be applied to tissue sections. In practice, ICC/IF are often used together when referring to fluorescent staining of cultured cells.
Should I fix with paraformaldehyde or methanol?
Aldehyde fixation generally preserves morphology and membrane architecture well, while methanol both fixes and permeabilises and can work better for selected cytoskeletal or otherwise fixation-sensitive epitopes. The antibody and target should determine the choice.
Do I always need permeabilisation?
No. Intracellular targets generally require it; accessible cell-surface epitopes may not. Unnecessary detergent exposure can damage membrane-associated targets.
How should I compare ICC intensity between treatments?
Use matched cell preparation and acquisition settings, avoid detector saturation, include biological replicates, and normalise only with a strategy that is stable under the experimental condition.
Related ABMIUM protocols
References and primary methods
- Bhattacharyya D, Hammond AT, Glick BS. High-quality immunofluorescence of cultured cells. Methods Mol Biol. 2010. PMID: 20419424.
- Protocol for iterative indirect immunofluorescence imaging in cultured cells, tissue sections and metaphase chromosome spreads. STAR Protocols. 2024.
Relevant ABMIUM products
Start with an antibody whose listed application includes IF/ICC and then validate it in your own cell model. One catalogue example is ABM161 Anti-Human Ki67 Antibody [3B7], which is listed for IHC and IF/ICC. This is an example of an application-matched listing, not a universal ICC control. For another target, browse primary antibodies or use Find your MATCH so we can compare application evidence, species reactivity and expected localisation before you buy.
Explore more with ABMIUM
For a different ICC target, use Find your MATCH with the target, species and cell model, or explore IF/ICC-compatible antibodies. Related methods: In-Cell ELISA and Immunofluorescence.